Abstract

Transcobalamin II-receptor (TC II-R) contains 10 half-cysteines, of which 8 are involved in intramolecular disulfide bonding. Reduction followed by alkylation with N-ethylmaleimide (NEM) of the 62-kDa TC II-R monomer in vitro or treatment of human intestinal epithelial Caco-2 cells with low concentrations (10(-6) M) of NEM resulted in TC II-R exhibiting a loss of ligand binding and an increase in its apparent molecular mass by 10 kDa to 72 kDa. Domain-specific biotinylation studies using NEM-treated filter-grown cells revealed loss of TC II-R but not cation-independent mannose 6-phosphate receptor protein at the basolateral cell surface. Pulse-chase labeling of NEM-treated cells with [35S]methionine revealed that the modified 72-kDa TC II-R, like the native 62-kDa TC II-R in untreated cells, turned over rapidly with a t1/2 of 7.5 h and was sensitive to treatment with peptide N-glycosidase F, sialidase alone, or sialidase and O-glycanase but not to treatment with endoglycosidase H. Labeled 72-kDa TC II-R, which was retained intracellularly following treatment of Caco-2 cells with methyl methanethiosulfonate, returned to the basolateral cell surface following withdrawal of cells from methyl methanethiosulfonate treatment and exposure to dithiothreitol. Based on these results, we suggest that formation and maintenance of intramolecular disulfide bonds of TC II-R is important for its acquisition of ligand binding and post-trans-Golgi trafficking to basolateral surface membranes but not for its turnover and exit from the endoplasmic reticulum or trafficking through the Golgi.

Highlights

  • The results of this study show that Transcobalamin II-receptor (TC II-R) monomers contain four intramolecular disulfide bonds that are required for activity and two free SH groups that have no role in ligand binding

  • SH Group Modification of Pure transcobalamin II (TC II)-R and Its Effect on Ligand Binding and SDS-PAGE Mobility—TC II-R reduced and treated with the sulfhydryl-modifying agents, NEM, IAM, or methyl methanethiosulfonate (MMTS) (Table I), was assayed for TC II-[57Co]Cbl binding by the DEAE-Sephadex method [16]

  • This method, which uses charge-based separation of receptor bound and free ligand, revealed .90% loss of ligand binding activity only when these reagents were added following the reduction of TC II-R in the presence of 4 M urea

Read more

Summary

THE JOURNAL OF BIOLOGICAL CHEMISTRY

Vol 272, No 33, Issue of August 15, pp. 20920 –20928, 1997 Printed in U.S.A. Effect of Disulfide Bonds of Transcobalamin II Receptor on Its Activity and Basolateral Targeting in Human Intestinal Epithelial Caco-2 Cells*. The secretion of nondisulfide bond-containing proteins such as a1-antitrypsin [14] in HepG2 cells or of a 20-kDa peptide derived from osteoponin in Madin-Darby canine kidney cells [13] is not affected These studies have proposed that the retention of proteins in the ER following treatment with DTT is due to a failure of these proteins to form disulfide bonds, which fold improperly. The increase in apparent molecular mass of the reduced TC II-R dimer may be related to its attainment of an extended or a more linear structure It is not known whether the TC II-R monomers contain intrachain disulfide bonds that, when reduced, form extended structures and whether such a modification has any effect on their ligand binding, turnover, and trafficking to the basolateral membranes. The 72-kDa form of TC II-R was unable to undergo transport from the trans-Golgi to its destination in the basolateral membranes

EXPERIMENTAL PROCEDURES
Disulfide Groups in Transcobalamin II Receptor
RESULTS
Ligand bound
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call